Innovating Works

INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA

Activa
Mostrando 1 al 20 de 26 resultados
IMMUTOL: ADVANCED ANTIGEN-SPECIFIC DENDRITIC CELL-BASED THERAPY TO RE-ESTABLISH TOLERANCE IN IMMUNE-MEDIATED... FONDAZIONE TELETHON ETS tramitó un HORIZON EUROPE: HORIZON-HLTH-2022-DISEASE-06-two-stage Autoimmune diseases are currently treated with immunosuppressive and supportive therapies, which dampen inflammation, but do not stop the ca...
2023-04-14 - 2027-04-30 | Financiado
OBGate: Creating an orthogonal gate to the brain INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un HORIZON EUROPE: ERC-2022-STG Many impairing illnesses raging from metastatic cancers to neurodegenerative diseases affect the brain. Unfortunately, delivery of therapeut...
2023-02-28 - 2028-05-31 | Financiado
PoPMeD-SuSDeV: Population Medicine and Sustainable Development European Opportunities in collaborating with China... INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-SE-01 The overarching objective of this Staff Exchanges (SE) program is to form an international network of organizations from Spain, Germany, Slo...
2022-10-17 - 2026-12-31 | Financiado
ISOBIOTICS: Isotopic Labeling of Biotherapeutics COMMISSARIAT A L ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-DN-01 Biological drugs such as peptides, proteins, oligonucleotides and analogs provide the patients with more efficacious and less toxic treatmen...
2022-07-14 - 2027-01-31 | Financiado
ADC2GBM: Development of brain-permeable masked nanobody-drug conjugates to eliminate glioma stem cells INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un HORIZON EUROPE: HORIZON-MSCA-2021-PF-01 Glioblastoma multiforme (GBM) is one of the most prevalent brain tumours and is currently incurable. Patients die from tumour recurrence aft...
2022-05-02 - 2024-04-30 | Financiado
EUROfusion: Implementation of activities described in the Roadmap to Fusion during Horizon Europe through a join... MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV tramitó un HORIZON EUROPE: EUROfusion’s updated Fusion Research Roadmap aims to acquire the necessary knowledge to start constructing a demonstration fusion power plan...
2021-12-07 - 2025-12-31 | Financiado
CHINEQUALJUSTICE: Testing the Chinese Development Model under the Capabilities Approach The Effects of Preferential P... INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un H2020: H2020-MSCA-IF-2018 The People's Republic of China (PRC) gradually transitions from an export-led and investment-driven economy towards a service-led and consum...
2019-10-22 - 2022-06-30 | Financiado
LIGHT4LUNGS: Inhalable Aerosol Light Source for Controlling Drug Resistant Bacterial Lung Infections INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un H2020: H2020-FETOPEN-2018-2020 Light4lungs addresses the problem of antimicrobial resistance in the treatment of chronic lung infections, which are the leading cause of mo...
2019-09-24 - 2024-05-31 | Financiado
TargetGBM: Generating a targeted brain permeable and stable polymeric nanoparticle for systemic gene delivery... INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un H2020: H2020-MSCA-IF-2018 Glioblastoma multiforme (GBM) is the most prevalent deadly brain tumour and is currently incurable. Patients die from recurrent tumours that...
2019-04-29 - 2021-06-30 | Financiado
EUROfusion: Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint... MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV tramitó un H2020: EURATOM-2024-NUCLEAR-Prize A Roadmap to the realization of fusion energy was adopted by the EFDA system at the end of 2012. The roadmap aims at achieving all the neces...
2014-09-30 - 2022-12-31 | Financiado
EUROfusion: Implementation of activities described in the Roadmap to Fusion during Horizon 2020 through a Joint... MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV tramitó un FP6: A Roadmap to the realization of fusion energy was adopted by the EFDA system at the end of 2012. The roadmap aims at achieving all the neces...
2014-01-01 - 2022-12-31 | Financiado
RECATABI: Regeneration of Cardiac Tissue Assisted by Bioactive Implants INSTITUT QUIMIC DE SARRIA CENTRE D ENSENYAMENT TECNIC SUPERIOR FUNDACIO PRIVADA tramitó un FP7: Heart failure is the end-stage of many cardiovascular diseases, but the leading cause is the presence of a large scar due acute to myocardia...
Financiado
NANO3BIO: NanoBioEngineering of BioInspired BioPolymers UNIVERSITAET MUENSTER tramitó un FP7: The Nano3Bio project convenes a consortium of world renowned experts from 8 EU universities, 1 large company, and 14 SME, to develop biotech...
Financiado
INTEG-RISK: Early Recognition Monitoring and Integrated Management of Emerging New Technology Related Risks EUROPEAN RISK RESILIENCE INSTITUTE EUVRI EWIV tramitó un FP7: INTeg-Risk is a large-scale integrating project aimed at improving the management of emerging risks in the innovative industry. This will be...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.